Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence

Abstract Tyrosine kinases are important therapeutic targets in drug discovery high-throughput screening programs. Homogeneous time-resolved fluorescence (HTRF) eliminates many of the problems associated with some conventional screening assay methodologies and this has made the development of tyrosine kinase HTRF assays an exciting prospect for pharmaceutical companies. The authors illustrate the utility of this technology in the light of experience within five pharmaceutical companies.

[1]  Alfred J. Kolb,et al.  Beyond the 96-Well Microplate: Instruments and Assay Methods for the 384-Well Format , 1997 .

[2]  G. Mathis,et al.  Europium(III) cryptate: a fluorescent label for the detection of DNA hybrids on solid support. , 1991, Analytical biochemistry.

[3]  N. Lydon,et al.  Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-src tyrosine protein kinase activity. , 1992, Analytical biochemistry.

[4]  S. Manly,et al.  Use of a Novel Homogeneous Fluorescent Technology in High Throughput Screening , 1996 .

[5]  Y. Gluzman,et al.  Development of a scintillation proximity assay for human cytomegalovirus protease using 33phosphorous. , 1996, Analytical biochemistry.

[6]  B. Strulovici,et al.  A chemiluminescent microtiter plate assay for sensitive detection of protein kinase activity. , 1997, Analytical biochemistry.

[7]  D. Lawrence,et al.  The design of peptide-based substrates for the cdc2 protein kinase. , 1995, The Biochemical journal.

[8]  G. Mathis,et al.  Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. , 1993, Clinical chemistry.

[9]  John G. Houston,et al.  A 384-HTS for Human Factor VIIa: Comparison With 96- and 864-Well Formats , 1997 .

[10]  K. Lipson,et al.  Measurement of the protein tyrosine kinase activity of c-src using time-resolved fluorometry of europium chelates. , 1996, Analytical biochemistry.

[11]  D. Heimbrook,et al.  Protein kinase inhibitors for the treatment of cancer , 1996 .